Abstract
Therapy with receptor tyrosine kinase inhibitors provides an improved treatment option in a number of diseases such as cancer, myocardial infection, osteoporosis, stroke, and neurodegeneration. We have designed, synthesized, and evaluated a series of novel 2-amino-5-[(benzyl)imino]methyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidine-4-one 7a and 2-amino-5-[(substituted-benzyl)imino]methyl-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidine-4-one 7b-e derivatives as potential tyrosine kinase inhibitors. These compounds were synthesized by condensation reaction using 2-tritylamino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carbaldehyde 5 and appropriate benzylamines followed by detritylation. Compounds were evaluated for their inhibitory activity toward tyrosine phosphorylation for the pp60c-Src tyrosine kinase. Compounds 7a, 7d, and 7e demonstrated potent inhibitory activities against pp60c-Src tyrosine kinase with IC50 values of 13.9, 34.5, and 78.4 microM, respectively. Dihalogenated compounds 7d and 7e have 3 to 7-times lower IC50 values than that of the parent compound 7a.
References
Jul 1, 1989·Journal of Medicinal Chemistry·E O OrlemansM C Bibby
Nov 21, 1995·Biochemistry·G C HoopsG A Garcia
Jan 12, 1996·The Journal of Biological Chemistry·J H HankeP A Connelly
Nov 14, 1997·Journal of Medicinal Chemistry·P TraxlerP Furet
Apr 17, 1999·The Journal of Biological Chemistry·V C TaylorS D Freeman
Apr 28, 1999·Advances in Cancer Research·J S BiscardiS J Parsons
Jul 15, 1999·Structure·X ZhuK A Morgenstern
Aug 24, 1999·Pharmacology & Therapeutics·J M Hamby, H D Showalter
May 10, 2000·Drugs·S B Noonberg, C C Benz
Aug 24, 2000·Journal of Medicinal Chemistry·A M ThompsonW A Denny
Mar 30, 2001·Bioorganic & Medicinal Chemistry Letters·L WidlerE Altmann
Mar 30, 2001·Bioorganic & Medicinal Chemistry Letters·E AltmannL Widler
Jun 1, 2001·Journal of Medicinal Chemistry·A GangjeeR L Kisliuk
Dec 26, 2001·Chemical Reviews·A J Bridges
Mar 8, 2002·Journal of Medicinal Chemistry·Laurent F HennequinJon O Curwen
Dec 31, 2002·Current Opinion in Structural Biology·Stevan R Hubbard
Jan 17, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alexander Levitzki
Oct 8, 2003·Current Pharmaceutical Design·Markus WarmuthNathanael Gray
Oct 28, 2003·Angewandte Chemie·Davide BonifaziFrançois Diederich
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark S DuxburyEdward E Whang
Apr 20, 2004·Critical Reviews in Oncology/hematology·Amar BennasrounePierre Hubert
May 15, 2004·Bioorganic & Medicinal Chemistry·Moustafa E El-ArabyWayne K Anderson
Jul 26, 2005·Bioorganic & Medicinal Chemistry·Aleem GangjeeFu-Tyan Lin
Aug 5, 2005·Journal of Medicinal Chemistry·Aleem GangjeeRoy L Kisliuk
Oct 28, 2005·Journal of Medicinal Chemistry·Miguel F BrañaLaurent Meijer
Sep 9, 2006·The Journal of Biological Chemistry·Yuh-Ping ChongHeung-Chin Cheng
Citations
Oct 22, 2011·International Journal of Molecular Sciences·Xiu E FengWen Han Lin
Jul 24, 2012·Marine Drugs·Banpeng CaoQiang Xiao
Aug 21, 2009·Chemical Biology & Drug Design·Zühal KiliçSüreyya Olgen
Dec 19, 2008·Chemical Biology & Drug Design·Yasemin G IşgörSüreyya Olgen
Jul 11, 2009·Organic & Biomolecular Chemistry·Colin L GibsonLindsay B Tulloch
May 29, 2009·Archiv der Pharmazie·Zuhal KiliçSüreyya Olgen
Oct 19, 2016·The Journal of Biological Chemistry·Jihye JungBernd Nidetzky
Jan 31, 2021·CNS Drugs·Meghan C Gage, Thimmasettappa Thippeswamy